Skip to content
10-Q

Quarterly Report

GeneThera, Inc.

0001477932-22-003629

← back to feed
Filed
May 18, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · May 17, 2022 34.08M sh
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$3.59K
Operating Cash Flow Q1 2022 · Mar 31, 2021 $0
Cash And Equivalents Q1 2022 · Mar 31, 2022 $0
Cash And Equivalents Q1 2022 · Dec 31, 2021 $0
Cash And Equivalents Q1 2022 · Mar 31, 2021 $0
Cash And Equivalents Q1 2022 · Dec 31, 2020 $0
Stockholders Equity Q1 2022 · Mar 31, 2022 −$8.31M
Stockholders Equity Q1 2022 · Dec 31, 2021 −$8.17M
Stockholders Equity Q1 2022 · Mar 31, 2021 −$7.83M
Stockholders Equity Q1 2022 · Dec 31, 2020 −$7.68M
Total Liabilities Q1 2022 · Mar 31, 2022 $8.31M
Total Liabilities Q1 2022 · Dec 31, 2021 $8.18M
Current Assets Q1 2022 · Mar 31, 2022 $0
Current Assets Q1 2022 · Dec 31, 2021 $1.02K
Total Assets Q1 2022 · Mar 31, 2022 $3.96K
Total Assets Q1 2022 · Dec 31, 2021 $6.3K
Net Income Q1 2022 · Mar 31, 2022 −$132.75K
Net Income Q1 2022 · Mar 31, 2021 −$206.24K
Operating Income Q1 2022 · Mar 31, 2022 −$132.19K
Operating Income Q1 2022 · Mar 31, 2021 −$204.6K